Dr Tasha Kynece Feaster, MD | |
1133 Eagles Landing Pkwy, Stockbridge, GA 30281-5085 | |
(770) 994-9326 | |
(770) 994-4747 |
Full Name | Dr Tasha Kynece Feaster |
---|---|
Gender | Female |
Speciality | Emergency Medicine |
Experience | 18 Years |
Location | 1133 Eagles Landing Pkwy, Stockbridge, Georgia |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1508071051 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207P00000X | Emergency Medicine | 062690 (Georgia) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Prattville Baptist Hospital | Prattville, AL | Hospital |
Baptist Medical Center East | Montgomery, AL | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Emergency Services Of Montgomery Pc | 6608028204 | 55 |
News Archive
Hair dye manufacturers are on notice: The cure for gray hair is coming. That's right, the need to cover up one of the classic signs of aging with chemical pigments will be a thing of the past thanks to a team of European researchers.
Debiopharm Group (Debiopharm), a Swiss-based global biopharmaceutical group of companies with a focus on the development of prescription drugs that target unmet medical needs and companion diagnostics, presented results of a Phase I open-label dose-escalation study with Debio 0932, an oral Heat Shock Protein 90 (HSP90) inhibitor in clinical development as an anti-cancer agent.
Digoxin may increase the risk of death in patients with atrial fibrillation (AF) by approximately 20%, according to results from the ROCKET AF trial presented at ESC Congress today by Dr Manesh Patel, director of interventional cardiology and catheterisation labs at Duke University Health System in Durham, North Carolina, US.
The American College of Rheumatology today applauded the Centers for Medicare and Medicaid Services' decision to withdraw a proposed rule to implement the "Most Favored Nation" payment model for Part B drugs.
Demand for home health care workers is soaring as baby boomers -; the 78 million Americans born between 1946 and 1964 -; get older and states try to save money by moving people out of more costly nursing homes.
› Verified 2 days ago
Entity Name | Paragon Contracting Services Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1225071459 PECOS PAC ID: 3971417825 Enrollment ID: O20050218000756 |
News Archive
Hair dye manufacturers are on notice: The cure for gray hair is coming. That's right, the need to cover up one of the classic signs of aging with chemical pigments will be a thing of the past thanks to a team of European researchers.
Debiopharm Group (Debiopharm), a Swiss-based global biopharmaceutical group of companies with a focus on the development of prescription drugs that target unmet medical needs and companion diagnostics, presented results of a Phase I open-label dose-escalation study with Debio 0932, an oral Heat Shock Protein 90 (HSP90) inhibitor in clinical development as an anti-cancer agent.
Digoxin may increase the risk of death in patients with atrial fibrillation (AF) by approximately 20%, according to results from the ROCKET AF trial presented at ESC Congress today by Dr Manesh Patel, director of interventional cardiology and catheterisation labs at Duke University Health System in Durham, North Carolina, US.
The American College of Rheumatology today applauded the Centers for Medicare and Medicaid Services' decision to withdraw a proposed rule to implement the "Most Favored Nation" payment model for Part B drugs.
Demand for home health care workers is soaring as baby boomers -; the 78 million Americans born between 1946 and 1964 -; get older and states try to save money by moving people out of more costly nursing homes.
› Verified 2 days ago
Entity Name | Emergency Services Of Montgomery Pc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1528310323 PECOS PAC ID: 6608028204 Enrollment ID: O20121205000519 |
News Archive
Hair dye manufacturers are on notice: The cure for gray hair is coming. That's right, the need to cover up one of the classic signs of aging with chemical pigments will be a thing of the past thanks to a team of European researchers.
Debiopharm Group (Debiopharm), a Swiss-based global biopharmaceutical group of companies with a focus on the development of prescription drugs that target unmet medical needs and companion diagnostics, presented results of a Phase I open-label dose-escalation study with Debio 0932, an oral Heat Shock Protein 90 (HSP90) inhibitor in clinical development as an anti-cancer agent.
Digoxin may increase the risk of death in patients with atrial fibrillation (AF) by approximately 20%, according to results from the ROCKET AF trial presented at ESC Congress today by Dr Manesh Patel, director of interventional cardiology and catheterisation labs at Duke University Health System in Durham, North Carolina, US.
The American College of Rheumatology today applauded the Centers for Medicare and Medicaid Services' decision to withdraw a proposed rule to implement the "Most Favored Nation" payment model for Part B drugs.
Demand for home health care workers is soaring as baby boomers -; the 78 million Americans born between 1946 and 1964 -; get older and states try to save money by moving people out of more costly nursing homes.
› Verified 2 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Tasha Kynece Feaster, MD 235 Peachtree St Ne, North Tower, Suite 2100, Atlanta, GA 30303-1401 Ph: (770) 994-9326 | Dr Tasha Kynece Feaster, MD 1133 Eagles Landing Pkwy, Stockbridge, GA 30281-5085 Ph: (770) 994-9326 |
News Archive
Hair dye manufacturers are on notice: The cure for gray hair is coming. That's right, the need to cover up one of the classic signs of aging with chemical pigments will be a thing of the past thanks to a team of European researchers.
Debiopharm Group (Debiopharm), a Swiss-based global biopharmaceutical group of companies with a focus on the development of prescription drugs that target unmet medical needs and companion diagnostics, presented results of a Phase I open-label dose-escalation study with Debio 0932, an oral Heat Shock Protein 90 (HSP90) inhibitor in clinical development as an anti-cancer agent.
Digoxin may increase the risk of death in patients with atrial fibrillation (AF) by approximately 20%, according to results from the ROCKET AF trial presented at ESC Congress today by Dr Manesh Patel, director of interventional cardiology and catheterisation labs at Duke University Health System in Durham, North Carolina, US.
The American College of Rheumatology today applauded the Centers for Medicare and Medicaid Services' decision to withdraw a proposed rule to implement the "Most Favored Nation" payment model for Part B drugs.
Demand for home health care workers is soaring as baby boomers -; the 78 million Americans born between 1946 and 1964 -; get older and states try to save money by moving people out of more costly nursing homes.
› Verified 2 days ago
Dr. Terry Ky-sieu Tran, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1133 Eagles Landing Pkwy, Stockbridge, GA 30281 Phone: 678-604-1000 | |
Yaa Manu, M.D Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1133 Eagles Landing Pkwy, Stockbridge, GA 30281 Phone: 678-604-1000 | |
Dr. Ajala Osagie Ngarndi, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1133 Eagles Landing Pkwy, Stockbridge, GA 30281 Phone: 678-604-1000 | |
Okiki Louis, MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 1133 Eagles Landing Pkwy, Stockbridge, GA 30281 Phone: 770-994-9326 Fax: 770-994-4747 | |
Hesiri M Fernando, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1133 Eagles Landing Pkwy, Stockbridge, GA 30281 Phone: 770-994-9326 Fax: 770-994-4747 | |
Jeffery Ray Mcgee, PA-C, AA-C Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1740 Hudson Bridge Rd, Suite 1218, Stockbridge, GA 30281 Phone: 678-604-1053 | |
Dr. Miles Anthony Medina, D.O. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1133 Eagles Landing Pkwy # Er, Stockbridge, GA 30281 Phone: 678-604-1000 |